News from Wisconsin Alzheimer's Institute
Dr. Mora Pinzon appointed to assistant professor
Dr. Mora Pinzon's work focuses on health services research in dementia care, and improving access to dementia care for Latinx individuals.
Dementia Matters episode discusses Lecanemab, the latest Alzheimer’s drug to receive FDA accelerated approval
On a recent episode of the Dementia Matters podcast, host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials.
Dr. Carlsson discusses approval of Alzheimer’s drug on CBS 58 news
Cynthia Carlsson, MD, MS, was recently interviewed by CBS 58 News in Milwaukee about the U.S. Food and Drug Administration (FDA) approval of Leqembi (lecanemab), which showed a reduction of clinical decline in a study …
FDA approves Alzheimer’s disease drug Lecanemab
On January 6, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications approved …
Amazing Grace Chorus performs holiday concert
How sweet the sound at a live, in person concert on December 17.
Dr. Johnson awarded Vilas Distinguished Achievement Professorship
Congratulations, Dr. Johnson!
- Read more news from WAI